Table 3. Effect of PG2 on CRP, ESR, IL-6, IL-1β, TNF-σ, and S100B in patients with acute spontaneous intracerebral hemorrhage.
| Variable | CG (%) (N = 31) | TG (%) (N = 30) | p-valuea |
|---|---|---|---|
| CRP (mg/L) | |||
| B | 0.7 ± 0.7 | 1.2 ± 3.2 | 0.9 |
| D4 | 1.8 ± 2.7 | 2.3 ± 4.2 | 0.9 |
| D7 | 1.9 ± 3.3 | 1.8 ± 2.8 | 0.9 |
| D14 | 1.2 ± 3.4 | 1.2 ± 2.3 | 0.9 |
| D4-B | 1.1 ± 2.6 | 1.1 ± 3.8 | 1.0 |
| D7-B | 1.2 ± 3.2 | 0.6 ± 2.6 | 0.6 |
| D14-B | 0.5 ± 3.0 | 0.1 ± 1.9 | 0.8 |
| ESR (mm/h) | |||
| B | 12.8 ± 9.7 | 14.9 ± 23.6 | 1.0 |
| D4 | 18.0 ± 10.5 | 19.2 ± 26.1 | 0.9 |
| D7 | 20.6 ± 13.1 | 23.0 ± 27.5 | 0.8 |
| D14 | 22.4 ± 18.9 | 24.3 ± 26.4 | 0.9 |
| D4-B | 5.2 ± 7.6 | 4.3 ± 8.4 | 0.8 |
| D7-B | 7.8 ± 9.8 | 8.1 ± 13.1 | 0.9 |
| D14-B | 9.7 ± 13.7 | 9.3 ± 13.1 | 0.9 |
| IL-6 (pg/ml) | |||
| B | 2.2 ± 3.37 | 2.2 ± 1.8 | 1.0 |
| D4 | 1.9 ± 3.01 | 3.6 ± 5.9 | 0.9 |
| D7 | 7.3 ± 30.2 | 2.4 ± 2.6 | 0.8 |
| D14 | 1.5 ± 2.2 | 1.9 ± 2.7 | 0.9 |
| D4-B | −0.3 ± 2.2 | 1.4 ± 6.2 | 0.7 |
| D7-B | 5.1 ± 30.4 | 0.2 ± 2.5 | 0.6 |
| D14-B | −0.7 ± 2.9 | −0.3 ± 2.5 | 0.8 |
| IL-1β (pg/ml) | |||
| B | 1.9 ± 1.7 | 2.7 ± 2.7 | 0.9 |
| D4 | 2.0 ± 1.8 | 2.3 ± 1.9 | 0.9 |
| D7 | 2.0 ± 1.7 | 2.2 ± 1.8 | 0.8 |
| D14 | 2.1 ± 2.0 | 1.9 ± 1.5 | 0.9 |
| D4-B | 0.1 ± 1.4 | −0.4 ± 2.7 | 0.7 |
| D7-B | 0.1 ± 1.5 | −0.5 ± 2.8 | 0.6 |
| D14-B | 0.2 ± 1.6 | −0.9 ± 2.4 | 0.2 |
| TNF-α (pg/ml) | |||
| B | 12.2 ± 29.4 | 13.3 ± 41.6 | 1.0 |
| D4 | 12.8 ± 31.2 | 11.6 ± 33.2 | 0.9 |
| D7 | 24.9 ± 57.8 | 8.0 ± 20.1 | 0.5 |
| D14 | 25.2 ± 53.2 | 4.9 ± 7.4 | 0.2 |
| D4-B | 0.6 ± 3.2 | −1.7 ± 10.1 | 0.7 |
| D7-B | 12.7 ± 49.0 | −5.4 ± 22.9 | 0.4 |
| D14-B | 13.1 ± 39.9 | −8.5 ± 36.6 | 0.2 |
| S100B (pg/ml) | |||
| B | 79.6 ± 143.0 | 57.2 ± 62.7 | 0.9 |
| D4 | 48.6 ± 55.0 | 40.4 ± 66.3 | 0.9 |
| D7 | 60.1 ± 79.2 | 35.8 ± 46.7 | 0.5 |
| D14 | 43.1 ± 61.0 | 34.5 ± 51.0 | 0.9 |
| D4-B | −31.0 ± 137.2 | −16.8 ± 87.0 | 0.8 |
| D7-B | −19.5 ± 112.2 | −21.4 ± 80.9 | 0.9 |
| D14-B | −36.5 ± 146.4 | −22.7 ± 83.2 | 0.8 |
Data presented as mean ± standard deviations. CG: control group; TG: treatment group; CRP: C-reactive protein; ESR: Erythrocyte sedimentation rate; IL-6: interleukin-6; IL-1β: interleukin-1β; TNF-α: tumor necrosis factor-α; S100B: S100B protein; B: baseline; D4: 4th day after intravenous injection of PG2; D7: 7th day after intravenous injection of PG2; D14: 14th day after intravenous injection of PG2; independent test for continuous data. acorrected p-value for multiple testing.